Skip to Main Content

Paper Details

Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Elife
21
2022
Alzheimer's, Cancer, DNA, DNA methylation, SNPs, breast, colorectal, prostate, ovarian and lung cancer, breast, prostate, colorectal, ovarian and lung cancer, cancer, cancers, colon cancer, colorectal cancer, epigenetic, genetic variants, multiple cancers, people, peoples, rectal cancer
Author NameAffiliation
Ake T LuDavid Geffen School of Medicine, University of California los angeles
Iona ChengCancer Prevention Institute of California
George Davey SmithUniversity of Bristol
George Davey SmithBristol Medical School
George Davey SmithUniversity of Bristol
George Davey SmithBristol Medical School
Caroline L ReltonUniversity of Bristol
Caroline L ReltonBristol Medical School
Steve HorvathDavid Geffen School of Medicine, University of California los angeles
Steve HorvathFielding School of Public Health, University of California los angeles
Riccardo E MarioniInstitute of Genetics and Cancer, University of Edinburgh
  • 1 - 11

Datasets

Release 1.2